Your browser doesn't support javascript.
loading
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
Wagner, Steve; Vlachogiannis, Georgios; De Haven Brandon, Alexis; Valenti, Melanie; Box, Gary; Jenkins, Liam; Mancusi, Caterina; Self, Annette; Manodoro, Floriana; Assiotis, Ioannis; Robinson, Penny; Chauhan, Ritika; Rust, Alistair G; Matthews, Nik; Eason, Kate; Khan, Khurum; Starling, Naureen; Cunningham, David; Sadanandam, Anguraj; Isacke, Clare M; Kirkin, Vladimir; Valeri, Nicola; Whittaker, Steven R.
Affiliation
  • Wagner S; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Vlachogiannis G; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • De Haven Brandon A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Valenti M; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Box G; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Jenkins L; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.
  • Mancusi C; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Self A; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Manodoro F; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Assiotis I; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Robinson P; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Chauhan R; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Rust AG; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Matthews N; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Eason K; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Khan K; Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.
  • Starling N; Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.
  • Cunningham D; Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.
  • Sadanandam A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Isacke CM; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.
  • Kirkin V; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Valeri N; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Whittaker SR; Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.
Oncogene ; 38(28): 5746, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31147600
ABSTRACT
A correction to this paper has been published and can be accessed via a link at the top of the paper.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: United kingdom